Betamethasone Sodium Phosphate and Betamethasone Acetate
- Product NDC
- 51754-5060
- 11-digit product format
- 517545060
- Labeler code
- 51754
- Product ID
- 51754-5060_7c09cbd4-df12-4b57-a03f-0db07c49da9f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE
- Labeler
- Exela Pharma Sciences, LLC
- Application
- NDA014602
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2021-06-01
- Marketing end
- 0000-00-00
- Substance
- BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
- Active strength
- 3 mg/mL; mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51754-5060-1 | 51754506001 | 1 VIAL, MULTI-DOSE in 1 BOX (51754-5060-1) > 5 mL in 1 VIAL, MULTI-DOSE | 2019-02-04 | 0000-00-00 | No | No | Current |